THRAP3 expression was found to be substantially linked with stage in 7 malignancies, including adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), KIRC, liver hepatocellular carcinoma (LIHC), and ovarian serous cystadenocarcinoma (OV). This evidence concerns the gene THRAP3 and head and neck squamous cell carcinoma.